The Chief Financial Officer of GSK, Julie Brown, has seen a significant milestone in her career as her 2023 Performance Share Plan award vested. This development, announced following its vesting date, reflects on the company’s promising growth and performance metrics.
CFO Julie Brown’s 2023 GSK Share Award Vests at 82%
On April 27, 2026, Julie Brown’s share award under the GSK 2017 Performance Share Plan (PSP) vested at a rate of 82%. This award was initially granted when she joined GSK as CFO Designate on April 27, 2023. The remaining 18% of the awarded shares lapsed, highlighting the company’s rigorous performance criteria.
Key Details of the Award
- Name: Julie Brown
- Position: Chief Financial Officer of GSK
- Award Date: April 27, 2023
- Vesting Date: April 27, 2026
- Vesting Percentage: 82%
- Lapsed Percentage: 18%
- Closing Share Price on Vesting Date: £20.16
- Shares Vested: 243,880 shares
In accordance with the company’s policies, the vested shares are subject to an additional holding period of two years. This aligns with GSK’s strategy to ensure that key executives remain invested in the company’s long-term growth.
Performance Metrics
The vesting outcomes are based on specific performance measures outlined in GSK’s announcement from February 17, 2026. These metrics serve as a benchmark for evaluating executive performance and aligning interests with those of shareholders.
The transaction is part of GSK’s commitment to reward its executives based on clear performance standards, fostering accountability and driving financial success in the company. Julie Brown’s successful vesting of the 2023 PSP award underscores her impactful role within GSK’s leadership team as the company continues to advance in the competitive pharmaceutical market.
